Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Ariad Pharmaceuticals Inc patents


Recent patent applications related to Ariad Pharmaceuticals Inc. Ariad Pharmaceuticals Inc is listed as an Agent/Assignee. Note: Ariad Pharmaceuticals Inc may have other listings under different names/spellings. We're not affiliated with Ariad Pharmaceuticals Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Ariad Pharmaceuticals Inc-related inventors


Crystalline forms of 5-chloro-n4-[-2-(dimethylphosphoryl) phenyl]-n2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl) piperidin-1-yl] pyrimidine-2,4-diamine

Crystalline forms of brigatinib, pharmaceutical compositions comprising the same, and methods of their preparation and use of the same are disclosed herein.. . ... Ariad Pharmaceuticals Inc

Ariad Pharmaceuticals, Inc.

. . ... Ariad Pharmaceuticals Inc

Heteroaryl compounds for kinase inhibition

Compounds and pharmaceutical compositions that modulate kinase activity, including mutant egfr and mutant her2 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including mutant egfr and mutant her2 activity, are described herein.. . ... Ariad Pharmaceuticals Inc

Phosphorous derivatives as kinase inhibitors

The invention features compounds of the general formula (i) in which the variable groups are as defined herein, and to their preparation and use.. . ... Ariad Pharmaceuticals Inc

Heteroaryl compounds for kinase inhibition

Compounds and pharmaceutical compositions that modulate kinase activity, including mutant egfr and mutant her2 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including mutant egfr and mutant her2 activity, are described herein.. . ... Ariad Pharmaceuticals Inc

Crystalline forms of 3-(imidazo[1,2-b] pyridazin-3-ylethynyl)-4-methyl-n-benzamide and its mono hydrochloride salt

Novel crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide free base and 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide mono hydrochloride, pharmaceutical compositions thereof and methods of their preparation and use are disclosed herein.. . ... Ariad Pharmaceuticals Inc

Heteroaryl compounds for kinase inhibition

Compounds and pharmaceutical compositions that modulate kinase activity, including mutant egfr and mutant her2 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including mutant egfr and mutant her2 activity, are described herein.. . ... Ariad Pharmaceuticals Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Ariad Pharmaceuticals Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Ariad Pharmaceuticals Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###